Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00505102
Status:
UNKNOWN
Last Update Posted:
2008-02-13
First Post:
2007-07-19
Brief Title:
Safe Renal Function In Long Term Heart Transplanted Patients
Sponsor:
AO Ospedale Papa Giovanni XXIII
Organization:
AO Ospedale Papa Giovanni XXIII
Study Overview
Official Title:
Efficacy and Safety of Everolimus to SAve REnal Function SAREFU in Long Term Heart Transplanted Patients
Status:
UNKNOWN
Status Verified Date:
2008-02
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SAREFU
Brief Summary:
The purpose of this study is to verify whether the reduction of cyclosporine dosages associated with Everolimus administration may improve renal function as compared to patients maintained on standard immunosuppressive therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None